BACKGROUND AND OBJECTIVES: The genetic alterations involved in extrahepatic bile duct (EHBD) cancer are poorly understood. Our aim was to identify aberrations of the K-ras, p53, and APC genes in EHBD cancer. METHODS: We investigated aberrations of these genes in 52 EHBD cancers using polymerase chain reaction (PCR) single-strand conformation polymorphism analysis, followed by direct sequence determination and a PCR restriction fragment length polymorphism assay. RESULTS: The K-ras, p53, and APC genes were mutated in 9.6%, 32.7%, and 0% of EHBD cancers, respectively. Loss of heterozygosity at the p53 and APC gene loci was identified in 15.6% and 38.5% of EHBD cancers, respectively. CONCLUSIONS: Our results suggest that an unknown suppressor gene on 5q other than the APC gene may be responsible for EHBD cancer.
BACKGROUND AND OBJECTIVES: The genetic alterations involved in extrahepatic bile duct (EHBD) cancer are poorly understood. Our aim was to identify aberrations of the K-ras, p53, and APC genes in EHBD cancer. METHODS: We investigated aberrations of these genes in 52 EHBD cancers using polymerase chain reaction (PCR) single-strand conformation polymorphism analysis, followed by direct sequence determination and a PCR restriction fragment length polymorphism assay. RESULTS: The K-ras, p53, and APC genes were mutated in 9.6%, 32.7%, and 0% of EHBD cancers, respectively. Loss of heterozygosity at the p53 and APC gene loci was identified in 15.6% and 38.5% of EHBD cancers, respectively. CONCLUSIONS: Our results suggest that an unknown suppressor gene on 5q other than the APC gene may be responsible for EHBD cancer.
Authors: N T van Heek; S J Clayton; P D J Sturm; J Walker; D J Gouma; L A Noorduyn; G J A Offerhaus; J C Fox Journal: J Clin Pathol Date: 2005-12 Impact factor: 3.411
Authors: Darrell R Borger; Kenneth K Tanabe; Kenneth C Fan; Hector U Lopez; Valeria R Fantin; Kimberly S Straley; David P Schenkein; Aram F Hezel; Marek Ancukiewicz; Hannah M Liebman; Eunice L Kwak; Jeffrey W Clark; David P Ryan; Vikram Deshpande; Dora Dias-Santagata; Leif W Ellisen; Andrew X Zhu; A John Iafrate Journal: Oncologist Date: 2011-12-16 Impact factor: 5.837
Authors: Vikram Deshpande; Afamefuna Nduaguba; Stephanie M Zimmerman; Sarah M Kehoe; Laura E Macconaill; Gregory Y Lauwers; Cristina Ferrone; Nabeel Bardeesy; Andrew X Zhu; Aram F Hezel Journal: BMC Cancer Date: 2011-02-08 Impact factor: 4.430
Authors: A F Hezel; M S Noel; J N Allen; T A Abrams; M Yurgelun; J E Faris; L Goyal; J W Clark; L S Blaszkowsky; J E Murphy; H Zheng; A A Khorana; G C Connolly; O Hyrien; A Baran; M Herr; K Ng; S Sheehan; D J Harris; E Regan; D R Borger; A J Iafrate; C Fuchs; D P Ryan; A X Zhu Journal: Br J Cancer Date: 2014-06-24 Impact factor: 7.640